参考文献/References:
[1] 麦尔哈巴·阿不都热依木, 潘燕. 非编码RNA 作为ceRNA 在人癌症中的功能及机制[J]. 中国生物化学与分子生物学报,2020,36(8):895-902.ABUDUREIMU·Malhaba, PAN Yan. The functionand mechanism of non-coding RNAs acting as ceRNAsin human cancer[J]. Chinese Journal of Biochemistryand Molecular Biology, 2020, 36 (8): 895-902.
[2] 李仪，赵洁，王俊斌．长非编码RNA 调控信号通路影响非小细胞肺癌的研究进展[J]. 齐齐哈尔医学院学报,2020,41(12):1517-1520.LI Yi, ZHAO Jie, WANG Junbin. Research progressof long non-coding RNA affecting non-small-cell lungcancer via regulating signaling pathway [J]. Journal ofQiqihar University of Medicine, 2020, 41 (12): 1517-1520.
[3] SONG Chunzi, SAKURAI M, SHIROMOTO Y, et al.Functions of the RNA editing enzyme ADAR1 andtheir relevance to human diseases[J]. Genes, 2016,7(12): 129.
[4] CHEN Jiajia，MIAO Zhijun，XUE Boxin， et al.Long non-coding RNAs in urologic malignancies:functional roles and clinical translation[J]. Journal ofCancer, 2016, 7(13): 1842-1855.
[5] KINGSHOTT G, BIERNACKA K, SEWELL A, etal. Alteration of metabolic conditions impacts theregulation of IGF-II/H19 imprinting status in prostatecancer[J]. Cancers, 2021, 13(4): 825.
[6] SONG Yanbin, LI Hua, REN Xiaoyue, et al. SNHG9,delivered by adipocyte-derived exosomes, alleviatesinflammation and apoptosis of endothelial cells throughsuppressing TRADD expression[J]. European Journalof Pharmacology, 2020, 872: 172977.
[7] LIN Yanli, HOLDEN V, DHILIPKANNAH P, et al. Anon-coding RNA landscape of bronchial epitheliums oflung cancer patients[J]. Biomedicines, 2020, 8(4): 88.
[8] WANG Ruixue, CHEN Changyu, KANG Weibiao, etal. SNHG9 was upregulated in NSCLC and associatedwith DDP-resistance and poor prognosis of NSCLCpatients[J]. American Journal of Translational Research,2020, 12(8): 4456-4466.
[9] WANG Dingxue, CAO Xiaoqing, HAN Yi, et al.LncRNA SNHG9 is downregulated in non-smallcell lung cancer and suppressed miR-21 throughmethylation to promote cell proliferation[J]. CancerManagement and Research, 2020, 12: 7941-7948.
[10] ZHANG Han, QIN Danxia, JIANG Zhixian, et al.SNHG9/miR-199a-5p/Wnt2 axis regulates cell growthand aerobic glycolysis in glioblastoma[J]. Journal ofNeuropathology and Experimental Neurology, 2019,78(10): 939-948.
[11] ZHANG Baogang, LI Changfeng, SUN Zhixia.Long non-coding RNA LINC00346, LINC00578,LINC00673, LINC00671, LINC00261, and SNHG9are novel prognostic markers for pancreatic cancer[J].American Journal of Translational Research, 2018,10(8): 2648-2658.
[12] CHEN Gaoyang, ZHANG Zhisheng, CHEN Yu, etal. Long non-coding RNA SNHG9 inhibits ovariancancer progression by sponging microRNA-214-5p[J].Oncology Letters, 2021, 21(2): 80.
[13] LI Chao, HU Jiao, HU Xiheng, et al. LncRNA SNHG9is a prognostic biomarker and correlated with immuneinfiltrates in prostate cancer[J]. Translational Andrologyand Urology, 2021, 10(1): 215-226.
[14] 郭梦玲．长链非编码RNA 与肺癌[J]. 中国肿瘤生物治疗杂志,2020,27(11):1289-1294.GUO Mengling. Long non-coding RNA and lungcancer [J]. Chinese Journal of Cancer Biotherapy, 2020,27 (11): 1289-1294.
[15] 许娟， 蔡长青， 李玉婵， 等． 长链非编码RNA在非小细胞肺癌诊断中的研究进展[J]. 海南医学,2020,31(14):1867-1871.XU Juan, CAI Changqing, LI Yuchan, et al. Diagnosticvalue of long non-coding RNA for non-small cell lungcancer [J]. Hainan Medical Journal, 2020, 31 (14):1867-1871.
[16] FAN Liming, HU Zhidong.Progress of long noncodingRNAs in non-small cell lung cancer(Article)[J].Chinese Journal of Lung Cancer, 2016, 19(2):108-112.
[17] WU Tao, YIN Xiaoxiang, ZHOU Yun, et al. Roles ofnoncoding RNAs in metastasis of nonsmall cell lungcancer: A mini review[J]. Journal of Cancer Researchand Therapeutics, 2015, 11 (Suppl 1): C7- C 10.
[18] 张亚琛, 梁迪, 靳晶, 等. 非小细胞肺癌相关lncRNA的研究进展[J]. 中国肺癌杂志,2018, 21(1):43-49.ZHANG Yachen, LIANG Di, JIN Jing, et al. Progress oflong non-coding RNA in non-small cell lung cancer] [J].Chinese Journal of Lung Cancer, 2018, 21(1):43-49.
[19] ZHANG Zhu, WANG Huahong. lncRNA SNHG1suppresses gastric cancer cell proliferation andpromotes apoptosis via notch1 pathway[J]. Journal ofB.U.ON, 2020, 25(1): 302-307.
[20] JIANG Tao, LIU Bingjie, WU Dongping, et al.BCLAF1 induces cisplatin resistance in lung cancercells[J]. Oncology Letters, 2020, 20(5): 227.
[21] JU Z S, SUN B, BAO D, et al. Effect of lncRNABLACAT1on drug resistance of non-small cell lungcancer cells in DDP chemotherapy by regulating cyclinD1 expression[J]. European Review for Medical andPharmacological Sciences, 2020, 24(18): 9465-9472.
[22] SUN Ruizheng, WANG Ranran, CHANG Siyuan, etal. Long non-coding RNA in drug resistance of nonsmallcell lung cancer: a mini review[J]. Frontiers inPharmacology, 2019, 10: 1457.
[23] WANG Leirong, MA Leina, XU Fei, et al. Role of longnon-coding RNA in drug resistance in non-small celllung cancer[J]. Thoracic Cancer, 2018, 9(7): 761-768.
[24] WANG Pei, CHEN Dong, MA Hongbing, et al.LncRNA MEG3 enhances cisplatin sensitivity in nonsmallcell lung cancer by regulating miR-21-5p/SOX7axis[J]. Onco Targets and Therapy, 2017, 10: 5137-5149.
[25] CAI Y, DONG Z Y, WANG J Y. LncRNA NNT-AS1 isa major mediator of cisplatin chemoresistance in nonsmallcell lung cancer through MAPK/Slug pathway[J].European Review for Medical and PharmacologicalSciences, 2018, 22(15): 4879-4887.
[26] SHANG J, XU Y D, ZHANG Y Y, et al. Longnoncoding RNA OR3A4 promotes cisplatin resistanceof non-small cell lung cancer by upregulating CDK1[J].European Review for Medical and PharmacologicalSciences, 2019, 23(10): 4220-4225.
[27] FENG Xiaomin, LIU Hao, ZHANG Zhijie, et al.Annexin A2 contributes to cisplatin resistance byactivation of JNK-p53 pathway in non-small cell lungcancer cells[J]. Journal of Experimental & ClinicalCancer Research, 2017, 36(1): 123.
[28] 南阳, 钟跃. 长非编码RNA 在神经胶质瘤研究中的新进展[J]. 国际肿瘤学杂志,2020,47(2):98-102.NAN Yang, ZHONG Yue. New research advancesof long non-coding RNA in glioma [J]. Journal ofInternational Oncology, 2020, 47 (2): 98-102.
[29] CHEN Qunbang, GAO Jian, ZHAO Yingjia, et al.Long non-coding RNA LBX2-AS1 enhances gliomaproliferation through downregulating microRNA-491-5p[J]. Cancer Cell International, 2020, 20(1): 411.
[30] CHEN Wanghao, LI Qiaoyu, ZHANG Guilong, et al.LncRNA HOXA-AS3 promotes the malignancy ofglioblastoma through regulating miR-455-5p/USP3axis[J]. Journal of Cellular and Molecular Medicine,2020, 24(20): 11755-11767.
[31] ZHU Xiaolong, JIANG Lan, YANG Hui, et al. Analyzingthe lncRNA, miRNA, and mRNA-associated ceRNAnetworks to reveal potential prognostic biomarkersfor glioblastoma multiforme[J]. Cancer Cell International,2020, 20(1): 393.
[32] ZHANG Xiaoming, NIU Wanxiang, MU Maolin, etal. Long non-coding RNA LPP-AS2 promotes gliomatumorigenesis via miR-7-5p/EGFR/PI3K/AKT/c-MYCfeedback loop[J]. Journal of Experimental & ClinicalCancer Research: CR, 2020, 39(1): 196.
[33] 丁莺，何洋，杨毅．长链非编码RNA 与胰腺相关疾病的研究进展[J]．中国现代医生，2020，58（16）：187-192．DING Ying, HE Yang, YANG Yi. Progress of the researchon long-chain non-coding RNA and pancreas relateddiseases [J]. China Modern Doctor, 2020, 58 (16):187-192.
[34] WANG Yizhi, ZHOU Li, LU Jun, et al. Researchprogress on long non-coding RNAs and their roles aspotential biomarkers for diagnosis and prognosis inpancreatic cancer[J]. Cancer Cell International, 2020,20(1): 457.
[35] CHEN A Y, ZHANG K, LIU G Q. LncRNA LINP1promotes malignant progression of pancreatic cancer byadsorbing microRNA-491-3p[J]. European Review forMedical and Pharmacological Sciences, 2020, 24(18):9315-9324.
[36] ZHAI Hongjun, ZHANG Xinwu, SUN Xiaoli, et al.Long non-coding RNA LINC01420 contributes topancreatic cancer progression through targeting KRASproto-oncogene[J]. Digestive Diseases and Sciences,2020, 65(4): 1042-1052.
[37] KIM K, JUTOORU I, CHADALAPAKA G, et al.HOTAIR is a negative prognostic factor and exhibitspro-oncogenic activity in pancreatic cancer[J].Oncogene, 2013, 32(13): 1616-1625.
[38] LIU Jianghua, CHEN Gang, DANG Yiwu, et al.Expression and prognostic significance of lncRNAMALAT1 in pancreatic cancer tissues[J]. Asian PacificJournal of Cancer Prevention, 2014, 15(7): 2971-2977.
[39] CHENG Yating, JUTOORU I, CHADALAPAKA G,et al. The long non-coding RNA HOTTIP enhancespancreatic cancer cell proliferation, survival andmigration[J]. Oncotarget, 2015, 6(13): 10840-10852.
[40] 张宇博，韩世愈．长链非编码RNA 在卵巢癌中的表达及作用的研究进展[J]．医学综述，2020，26(13):2575-2579.ZHANG Yubo, HAN Shiyu. Research progress inexpression and role of long non-coding RNA in ovariancancer [J]. Medical Recapitulate, 2020, 26 (13): 2575-2579.
[41] 陈颖安, 程艳萍, 杨圣, 等. 长链非编码RNA 多态性和女性常见肿瘤易感性的研究进展[J]. 现代预防医学,2020,47(14):2607-2610,2647.CHEN Ying’an, CHENG Yanping, YANG Sheng,et al. Research progress of long non-coding RNApolymorphisms and susceptibility to common tumorsin women [J]. Modern Preventive Medicine, 2020, 47(14): 2607-2610，2647
[42] 孙大林, 金保方, 蔡滨, 等. 长链非编码RNAH19 在生殖系统中的研究进展[J]. 生殖医学杂志,2021,30(1):125-130.SUN Dalin, JIN Baofang, CAI Bin, et al. Researchprogress of long non-coding RNA H19 in reproductivesystem [J]. Journal of Reproductive Medicine, 2021,30(1): 125-130.
相似文献/References:
[1]祖瑞铃,叶波.不同肿瘤与并发胰腺炎患者血清AMY和LPS的分布水平及实验诊断价值研究[J].现代检验医学杂志,2019,34(01):76.[doi:10.3969/j.issn.1671-7414.2019.01.019]
ZU Rui-ling,YE Bo.Distributions and Diagnostic Values of Serum Amylase and Lipase
in Patients with Various Types of Tumors and Those with Pancreatitis[J].Journal of Modern Laboratory Medicine,2019,34(04):76.[doi:10.3969/j.issn.1671-7414.2019.01.019]
[2]王李秦,魏绪仓.Galectin-4与肿瘤相关性的研究进展[J].现代检验医学杂志,2019,34(01):161.[doi:10.3969/j.issn.1671-7414.2019.01.042]
WANG Li-qin,WEI Xu-cang.Research of Galectin-4 in Tumor[J].Journal of Modern Laboratory Medicine,2019,34(04):161.[doi:10.3969/j.issn.1671-7414.2019.01.042]
[3]左二冬,代 卫,陆 晔,等.放疗相关性贫血患者血清Hepcidin，EPO 表达特征[J].现代检验医学杂志,2020,35(02):43.[doi:10.3969/j.issn.1671-7414.2020.02.013]
ZUO Er-dong,DAI Wei,LU Ye,et al.Expression Features of Serum Hepcidin and EPO in Tumor Patients withRadiotherapy-Related Anemia[J].Journal of Modern Laboratory Medicine,2020,35(04):43.[doi:10.3969/j.issn.1671-7414.2020.02.013]
[4]王秋云,严 敏,程 珍,等.肿瘤及血液病患者血清 sTRAIL表达及与 IL-6和 Hepcidin水平的相关性研究[J].现代检验医学杂志,2021,36(01):58.[doi:10.3969/j.issn.1671-7414.2021.01.015]
WANG Qiu-yun,YAN Min,CHENG Zhen,et al.Study of the Expression of the Serum sTRAIL, and Its Correlation with Levels of Serum IL-6 and Hepcidin in the Patients with the Tumor and Hematological Diseases[J].Journal of Modern Laboratory Medicine,2021,36(04):58.[doi:10.3969/j.issn.1671-7414.2021.01.015]
[5]夏艳艳,沈 瀚,许红攀,等.液体活检技术在肿瘤诊断中的最新研究进展[J].现代检验医学杂志,2021,36(03):157.[doi:10.3969/j.issn.1671-7414.2021.03.037]
XIA Yan-yan,SHEN Han,XU Hong-pan,et al.Latest Research Progress of Liquid Biopsy in Tumor Diagnosis[J].Journal of Modern Laboratory Medicine,2021,36(04):157.[doi:10.3969/j.issn.1671-7414.2021.03.037]
[6]刘振亚,赵慧敏,王临艳.血清淀粉样蛋白A 与肿瘤诊断、分期和预后相关性研究进展[J].现代检验医学杂志,2023,38(03):207.[doi:10.3969/j.issn.1671-7414.2023.03.039]
LIU Zhen-ya,ZHAO Hui-min,WANG Lin-yan.Advances on the Correlation between Serum Amyloid A and Cancer Diagnosis, Stage and Prognosis[J].Journal of Modern Laboratory Medicine,2023,38(04):207.[doi:10.3969/j.issn.1671-7414.2023.03.039]
[7]刁 迅,范绮雨,耿良栋,等.基于生物信息学分析双硫死亡相关基因PDLIM1 mRNA在多种肿瘤中的表达及临床应用价值[J].现代检验医学杂志,2024,39(01):36.[doi:10.3969/j.issn.1671-7414.2024.01.007]
DIAO Xun,FAN Qiyu,GENG Liangdong,et al.Analysis of Expression in Disulfidptosis-Related Gene PDLIM1 mRNA in Various Tumors and Its Clinical Application Value Based on Bioinformatics[J].Journal of Modern Laboratory Medicine,2024,39(04):36.[doi:10.3969/j.issn.1671-7414.2024.01.007]